BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33436737)

  • 1. Precise enhancement quantification in post-operative MRI as an indicator of residual tumor impact is associated with survival in patients with glioblastoma.
    Garcia-Ruiz A; Naval-Baudin P; Ligero M; Pons-Escoda A; Bruna J; Plans G; Calvo N; Cos M; Majós C; Perez-Lopez R
    Sci Rep; 2021 Jan; 11(1):695. PubMed ID: 33436737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.
    Kuhnt D; Becker A; Ganslandt O; Bauer M; Buchfelder M; Nimsky C
    Neuro Oncol; 2011 Dec; 13(12):1339-48. PubMed ID: 21914639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated Volumetric Analysis of Postoperative Magnetic Resonance Imaging Predicts Survival in Patients with Glioblastoma.
    Krivoshapkin AL; Sergeev GS; Gaytan AS; Kalneus LE; Kurbatov VP; Abdullaev OA; Salim N; Bulanov DV; Simonovich AE
    World Neurosurg; 2019 Jun; 126():e1510-e1517. PubMed ID: 30910753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastoma.
    De Barros A; Attal J; Roques M; Nicolau J; Sol JC; Cohen-Jonathan-Moyal E; Roux FE
    J Neurooncol; 2019 May; 142(3):489-497. PubMed ID: 30783874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
    Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
    Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Tumor Volume in Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection.
    Bette S; Barz M; Wiestler B; Huber T; Gerhardt J; Buchmann N; Combs SE; Schmidt-Graf F; Delbridge C; Zimmer C; Kirschke JS; Meyer B; Ryang YM; Ringel F; Gempt J
    Ann Surg Oncol; 2018 Feb; 25(2):558-564. PubMed ID: 29159745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
    Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
    J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.
    Chaichana KL; Jusue-Torres I; Navarro-Ramirez R; Raza SM; Pascual-Gallego M; Ibrahim A; Hernandez-Hermann M; Gomez L; Ye X; Weingart JD; Olivi A; Blakeley J; Gallia GL; Lim M; Brem H; Quinones-Hinojosa A
    Neuro Oncol; 2014 Jan; 16(1):113-22. PubMed ID: 24285550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
    Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
    Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
    [No Abstract]   [Full Text] [Related]  

  • 11. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Two-Dimensional Size of Glioblastoma is Associated with Patient Survival.
    Leu S; Boulay JL; Thommen S; Bucher HC; Stippich C; Mariani L; Bink A
    World Neurosurg; 2018 Jul; 115():e448-e463. PubMed ID: 29678715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational study.
    De Barros A; Attal J; Roques M; Nicolau J; Sol JC; Charni S; Cohen-Jonathan-Moyal E; Roux FE
    Clin Neurol Neurosurg; 2020 Sep; 196():105972. PubMed ID: 32512407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Operative Perfusion Skewness and Kurtosis Are Potential Predictors of Progression-Free Survival after Partial Resection of Newly Diagnosed Glioblastoma.
    Paik W; Kim HS; Choi CG; Kim SJ
    Korean J Radiol; 2016; 17(1):117-26. PubMed ID: 26798224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study Protocol: Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma (Gamma-GBM).
    Brehmer S; Grimm MA; Förster A; Seiz-Rosenhagen M; Welzel G; Stieler F; Wenz F; Groden C; Mai S; Hänggi D; Giordano FA
    Neurosurgery; 2019 May; 84(5):1133-1137. PubMed ID: 29688510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
    Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
    Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
    Orringer D; Lau D; Khatri S; Zamora-Berridi GJ; Zhang K; Wu C; Chaudhary N; Sagher O
    J Neurosurg; 2012 Nov; 117(5):851-9. PubMed ID: 22978537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.
    Aldave G; Tejada S; Pay E; Marigil M; Bejarano B; Idoate MA; Díez-Valle R
    Neurosurgery; 2013 Jun; 72(6):915-20; discussion 920-1. PubMed ID: 23685503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.